HPV Vaccine Reminders - SEARCH II Study
SEARCH II: Short Message Service (SMS) Electronic Adolescent Reminders for Completion of HPV Vaccination - Uganda: Randomized Controlled Trial
2 other identifiers
interventional
396
2 countries
2
Brief Summary
This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2023
CompletedFirst Posted
Study publicly available on registry
December 8, 2023
CompletedStudy Start
First participant enrolled
April 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
September 8, 2025
September 1, 2025
2.1 years
November 30, 2023
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time to Receipt of First HPV Vaccine Dose
Timeliness of vaccination (time to event) will be measured
12 months
Time to Receipt of Second HPV Vaccine Dose
Timeliness of vaccination (time to event) will be measured
12 months
Study Arms (2)
Text message/automated phone reminders
EXPERIMENTALText message or automated phone reminders
Usual Care
NO INTERVENTIONNo reminders
Interventions
Receipt of text message or automated phone reminders notifying when the next HPV vaccine dose is due (either first or second)
Eligibility Criteria
You may qualify if:
- Be a parenting adult of an adolescent girl aged 10-14 years
- Reside in Kampala and/or the surrounding districts
- Speak English or Luganda
- Have a cell phone with text messaging capability
- Must have ability to consent
You may not qualify if:
- Parenting adult speaks other language than English or Luganda only
- Parenting adult already enrolled in the study for another child
- Participation in previous HPV vaccine reminder study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- Makerere Universitycollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (2)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Makerere University/Mulago Hospital
Kampala, Uganda
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa S Stockwell, MD MPH
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics and Population and Family Health
Study Record Dates
First Submitted
November 30, 2023
First Posted
December 8, 2023
Study Start
April 22, 2024
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
September 8, 2025
Record last verified: 2025-09